Skip to content
FDA panel approves Moderna recall for high-risk groups six months after vaccination


An FDA advisory group voted unanimously to recommend the booster of Moderna’s COVID-19 vaccine six months after the initial vaccination for vulnerable Americans. People included in the recommendation are people aged 65 and over, adults with underlying health conditions, and those at increased risk of contracting the virus due to their work. Dr. Shad Marvasti, director of public health, prevention and promotion and associate professor at the University of Arizona College of Medicine in Phoenix, joins CBSN to discuss the latest news.